Fidelity Investments’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
Fidelity Investments's RCUS Position: Q3 2026 in Review
Fidelity Investments increased its Arcus Biosciences (RCUS) stake by 9.6% in Q3 2026, buying an estimated $10.9M and bringing the position to 4,436,585 shares worth $115M. The position accounts for ﹤0.01% of the portfolio, ranked #1165.
Fidelity Investments first reported a position in RCUS in Q2 2019 and has held it in 28 quarters since. The position peaked at $129M in Q4 2021. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Fidelity Investments held 4,436,585 shares of Arcus Biosciences worth $115M as of Q3 2026.
- Fidelity Investments bought 386,828 Arcus Biosciences shares in Q3 2026, an estimated $10.9M.
- Arcus Biosciences made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #1165 holding.
- Fidelity Investments first reported a position in Arcus Biosciences in Q2 2019 and has held it in 28 quarters since.
- Fidelity Investments's Arcus Biosciences position peaked at $129M in Q4 2021.
- 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.